{
    "organizations": [],
    "uuid": "5eb995ece95c71186940b424283e2cabf348c95d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vistin-pharma-q1-ebitda-from-conti/brief-vistin-pharma-q1-ebitda-from-continuing-operations-up-at-nok-6-3-million-idUSASO0003UT",
    "ord_in_thread": 0,
    "title": "Vistin Pharma Q1 EBITDA From Continuing Operations Up At NOK 6.3 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - VISTIN PHARMA ASA:\n* REG-VISTIN PHARMA ASA : DELIVERS 22% REVENUE GROWTH IN FIRST QUARTER 2018\n* Q1 REVENUE NOK 52.8 MILLION VERSUS NOK 43.4 MILLION YEAR AGO\n* EBITDA FROM CONTINUING OPERATIONS CAME TO NOK 6.3 MILLION FOR Q1, COMPARED TO NOK 5.2 MILLION Q1 LAST YEAR Source text for Eikon: (Gdynia Newsroom)\n ",
    "published": "2018-04-26T13:06:00.000+03:00",
    "crawled": "2018-04-27T16:27:28.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "vistin",
        "pharma",
        "asa",
        "pharma",
        "asa",
        "delivers",
        "revenue",
        "growth",
        "first",
        "quarter",
        "q1",
        "revenue",
        "nok",
        "million",
        "versus",
        "nok",
        "million",
        "year",
        "ago",
        "ebitda",
        "continuing",
        "operation",
        "came",
        "nok",
        "million",
        "q1",
        "compared",
        "nok",
        "million",
        "q1",
        "last",
        "year",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}